Intended for healthcare professionals

Letters Hypercholesterolaemia

Clarifications from adverse drug reactions agency

BMJ 2008; 337 doi: (Published 16 September 2008) Cite this as: BMJ 2008;337:a1669
  1. Anthony Cox, pharmacovigilance pharmacist
  1. 1West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham B18 7QH
  1. anthony.cox{at}

    Struthers’s letter on reasons to be cautious about cholesterol lowering drugs may have misled readers in suggesting that the West Midlands Centre for Adverse Drug Reactions (CADRe) had issued a warning about a potential increased risk of cancer associated …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription